Fusion of human bone hemopoietic stem cell with esophageal carcinoma cells didn’t generate esophageal cancer stem cell

Neoplasma

Volumn 61, Issue 5, 2014, Pages 540-545

  Fan, H ^a   Lu, S ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Cancer stem cells; Cell fusion; Esophageal cancer; Hemopoietic stem cells

Indexed keywords

CISPLATIN; FLUOROURACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CANCER STEM CELL; CARCINOGENESIS; CELL FUSION; CELL GROWTH; CELL PROLIFERATION; CELL SELECTION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DRUG SENSITIVITY; ESOPHAGUS CARCINOMA; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; MTT ASSAY; NONHUMAN; TUMOR XENOGRAFT; ANIMAL; CYTOLOGY; DRUG RESISTANCE; ESOPHAGEAL NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL FUSION; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; NEOPLASTIC STEM CELLS;

EID: 84907285209     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2014_066     Document Type: Article

References (28)

1. BJERKVIG R, TYSNES BB, ABOODY KS, NAJBAUER J, TERZIS AJ. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 2005; 5: 899–904. http://dx.doi.org/10.1038/nrc1740
2. HUNTLY BJ, GILLILAND DG. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer 2005; 5: 311–321. http://dx.doi.org/10.1038/nrc1592
3. SINGH SK, HAWKINS C, CLARKE ID, SQUIRE JA, BAYANI J et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396–401. http://dx.doi.org/10.1038/nature03128
4. DUELLI D, LAZEBNIK Y. Cell fusion: a hidden enemy? Cancer Cell 2003; 3: 445–448. http://dx.doi.org/10.1016/S1535-6108(03)00114-4
5. AICHEL O. Über Zellverschmelzung mit qualitativ abnormer Chromosomenverteilung als Ursache der Geschwulstbildung. Vorträge Und Aufsätze Über Entwicklungsmechanik Der Organismen 1911.
6. SHACKLETON M, QUINTANA E, FEARON ER, MORRISON SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009; 138: 822–829. http://dx.doi.org/10.1016/j.cell.2009.08.017
7. PAWELEK JM. Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 2005; 6: 988–993. http://dx.doi.org/10.1016/S1470-2045(05)70466-6
8. KERBEL RS, LAGARDE AE, DENNIS JW, DONAGHUE TP. Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor. Mol Cell Biol 1983; 3: 523–538.
9. WANG Y, FAN H, ZHOU B, JU Z, YU L et al. Fusion of human umbilical cord mesenchymal stem cells with esophageal carcinoma cells inhibits the tumorigenicity of esophageal carcinoma cells. Int J Oncol 2012; 40: 370–377.
10. THORSTEN SCHLAEGER, EDITOR. Curr Protoc Stem Cell Biol, New York: John Wiley & Sons, 2009.
11. MORGAN SA, WATSON JV, TWENTYMAN PR, SMITH PJ. Flow cytometric analysis of Hoechst 33342 uptake as an indicator of multi-drug resistance in human lung cancer. Br J Cancer. 1989; 60: 282–287. http://dx.doi.org/10.1038/bjc.1989.271
12. HOUGHTON J, STOICOV C, NOMURA S, ROGERS AB, CARLSON J et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306: 1568–15671. http://dx.doi.org/10.1126/science.1099513
13. KLEIN G, BREGULA U, WIENER F, HARRIS H. The analysis of malignancy by cell fusion. I. Hybrids between tumour cells and L cell derivatives. J Cell Sci 1971; 8: 659–672.
14. HARRIS H, WIENER F, AND KLEIN G. The analysis of malignancy by cell fusion. 3. Hybrids between diploid fibroblasts and other tumour cells. J Cell Sci 1971; 8: 681–692.
15. WIENER F, KLEIN G, AND HARRIS H. The analysis of malignancy by cell fusion. IV. Hybrid between tumour cells and a malignant L cell derivative. J Cell Sci 1973; 12: 253–261.
16. WIENER F, KLEIN G, AND HARRIS H. The analysis of malignancy by cell fusion. VI. Hybrids between different tumour cells. J Cell Sci 1974; 16: 189–198.
17. RIZVI AZ, SWAIN JR, DAVIES PS, BAILEY AS, DECKER AD et al. Bone marrow-derived cells fuse w ith normal and transformed intestinal stem cells. Proc Natl Acad Sci U S A 2006; 103: 6321–5. http://dx.doi.org/10.1073/pnas.0508593103
18. WEIMANN JM, CHARLTON CA, BRAZELTON TR, HACKMAN RC, BLAU HM. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci U S A 2003; 100: 2088–2093. http://dx.doi.org/10.1073/pnas.0337659100
19. FERRARI G, Cusella-De Angelis G, COLETTA M, PAOLUCCI E et al. Muscle regeneration by bone marrowderived myogenic progenitors. Science 1998; 279: 1528–1530. http://dx.doi.org/10.1126/science.279.5356.1528
20. VASSILOPOULOS G, WANG PR, AND RUSSELL DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003; 422: 901–904. http://dx.doi.org/10.1038/nature01539
21. WANG X, WILLENBRING H, AKKARI Y, TORIMARU Y, FOSTER M et al. Cell fusion is the principal source of bonemarrow- derived hepatocyte. Nature 2003; 422: 897–901. http://dx.doi.org/10.1038/nature01531
22. HUANG D, GAO Q, GUO L, ZHANG C, JIANG W et al. Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev 2009; 18: 465–473. http://dx.doi.org/10.1089/scd.2008.0033
23. WANG J, GUO LP, CHEN LZ, ZENG YX, LU SH. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 2007; 67: 3716–3724. http://dx.doi.org/10.1158/0008-5472.CAN-06-4343
24. PARDAL R, CLARKE MF AND MORRISON SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003; 3: 895–902. http://dx.doi.org/10.1038/nrc1232
25. DEAN M, FOJO T, AND BATES S. Tumor stem cells and drug resistance. Nat Rev Cancer 2005; 5: 275–84. http://dx.doi.org/10.1038/nrc1590
26. HERMANN PC, HUBER SL, HERRLER T, AICHER A, ELLWART JW et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1: 313–323. http://dx.doi.org/10.1016/j.stem.2007.06.002
27. PETERS BA, DIAZ LA, POLYAK K, MESZLER L, ROMANS K et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 2005; 11: 261–262. http://dx.doi.org/10.1038/nm1200
28. LYDEN D, HATTORI K, DIAS S, COSTA C, BLAIKIE P et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7: 1194–1201. http://dx.doi.org/10.1038/nm1101-1194